Driving, medicinal cannabis and NZ's roadside drug testing

Of all the practical issues facing medicinal cannabis patients, driving is the one with the highest stakes and the most confusion. New Zealand has introduced random roadside oral-fluid (saliva) drug testing, and the rules are not what many patients assume. This article explains the landscape as it stood in mid-2026 — but driving law changes, so always check the current details with NZ Police and NZTA before relying on them.

What's changed

Random roadside oral-fluid testing began in Wellington on 15 December 2025, with a nationwide rollout targeted around mid-2026. The roadside screening test detects THC, methamphetamine, MDMA and cocaine.

The mechanics, as described in official material: two positive roadside tests trigger an automatic 12-hour driving prohibition, after which an evidential sample may be taken. A screening cut-off of around 15 ng/mL of THC in oral fluid has been reported for the roadside device, with separate, lower blood-THC evidential thresholds described in clinical guidance — but the exact operative numbers should be confirmed with Police/NZTA, as they can change.

The critical points for patients

This is where patient assumptions most often go wrong:

• A prescription does not exempt you from being tested, and it is not an immediate defence at the roadside. Two positive tests mean the 12-hour ban applies regardless of whether you have a valid prescription.
• A medical defence can be applied retrospectively. If you have a valid prescription, the pharmacy label and proof that you were using the product as directed, that can form a defence after the fact — but it does not stop the roadside consequences in the moment.
• It is always illegal to drive while impaired, prescription or not. No defence covers impaired driving. The clinical guidance is simple: don't drive "until it is clear how the product affects you."

How long does THC linger?

This is genuinely tricky, because saliva detection and impairment are not the same thing, and both vary a lot between people, products and doses. THC can persist in saliva for hours after use. General (non-legal, non-guaranteed) guides have suggested waiting at least around six hours after inhaling and at least ten hours after an oral THC dose before driving — but these are rules of thumb, not safe-harbour limits, and they offer no legal protection. Oral products in particular last a long time, sometimes well into the next day.

CBD-only products are not the target of the roadside THC screen, but if your product contains any meaningful THC, the above applies.

Practical risk management

• Talk to your prescriber specifically about driving. Ask how your product and dose are likely to affect you and how long to wait.
• Time your doses around driving. Evening dosing of a sedating THC product, with no morning drive, is a common approach.
• Never drive while you feel any effect — drowsiness, slowed reactions, altered perception.
• Carry your documentation. Keep your prescription details and pharmacy-labelled product with you; they support a retrospective medical defence.
• Plan alternatives for the period after dosing if there's any chance you'll be tested or impaired.
• Tell your employer if relevant. Some jobs (driving, heavy machinery, safety-sensitive roles) have their own drug policies that a prescription may not override.

Why saliva detection isn't the same as impairment

One source of confusion deserves spelling out. The roadside test detects the presence of THC above a threshold; it is not a direct measure of how impaired you are at that moment. THC can be detectable in saliva after the impairing effects have faded, and conversely impairment can be present without a clean correspondence to any single number. This is part of why the law combines a presence-based roadside screen with an absolute prohibition on impaired driving — and why patients can't rely on "I feel fine" as a defence against a positive test, nor on a negative feeling as proof they're under the threshold. The only reliable strategy is time and abstinence from driving while THC is active.

CBD-only patients

If your product is a genuine CBD product (CBD at least 98% of the cannabinoids, THC at 2% or less), the roadside THC screen is not aimed at you, and CBD is non-intoxicating. That said, always confirm the actual THC content of your product with your prescriber and pharmacist — some products marketed loosely as "CBD" contain more THC than the legal CBD-product definition allows. If there's meaningful THC in the bottle, treat it like any other THC product for driving purposes.

The honest summary

The legal framework gives medicinal cannabis patients a retrospective medical defence, not a roadside pass. The combination of automatic 12-hour bans on two positive tests, plus the absolute rule against impaired driving, means the only safe strategy is to plan your dosing so you are never driving with THC active or impairment present. When in doubt, don't drive — and verify the current thresholds and rollout status with NZ Police and NZTA.

Last reviewed 10 August 2026 — education, not medical advice; not legal advice. Confirm current rules with NZ Police and NZTA. Sources: NZ Police — drug driving updates; NZ Drug Foundation — roadside drug testing.